A double blind, randomised placebo controlled study of the safety, reactogenicity and immunogenicity of two doses of orally administered human rotavirus vaccine (RIX4414) in healthy infants in South A...

Update Il y a 4 ans
Reference: ISRCTN37373664

A double blind, randomised placebo controlled study of the safety, reactogenicity and immunogenicity of two doses of orally administered human rotavirus vaccine (RIX4414) in healthy infants in South Africa

Woman and Man

Extract

Not provided at time of registration


Inclusion criteria

  • Vaccine/immunization

Links